biotech

Amyris Biotechnologies Raises $20 Million in Series A Funding

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Energy, Environment and Ecology on October 12, 2006

Amyris Biotechnologies Raises $20 Million in Series A Funding
Amyris Biotechnologies, Inc., a privately-held company applying advances in synthetic biology to produce high-value pharmaceuticals, fine chemicals and biofuels, has raised $20 million in a first round of venture funding. Additionally, the firm also announced the appointment of John G. Melo, previously president of U.S. Fuels Operations for bp plc., as CEO.
"...These new resources will enable the company to expand its capabilities to address major global health and energy challenges, thereby helping to fulfill the promise of synthetic biology, ... In addition to its ongoing focus on creating a low-cost malaria drug, Amyris will add a new program aimed at renewably producing second-generation, high-performance biofuels with increased cost-effectiveness."

Amyris has a collaborative project with the University of California, Berkeley, and the Institute for One World Health (iOWH) to develop a cost-effective malaria treatment.

Read more from Amyris' press release.

Permalink: Amyris Biotechnologies Raises $20 Million in Series A Funding

Tags: venture+funding  synthetic+biology  biofuels  malaria    biotech  raises+million  amyris+biotechnologies 

Vote for Amyris Biotechnologies Raises $20 Million in Series A Funding:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 2 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells